Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Peptic Ulcer Disease IV: Management
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Peptic Ulcer Disease I: Introduction
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Thomas Matthews1, Mark Vesey2,3, Aditya Billur3
1Department of Gastroenterology, Mater Misericordiae University Hospital, Dublin, Ireland. thomasmatthews@mater.ie.
具有良性特征和适当组织学的胃 (GUs) 的例行重新评估提供了最小的益处,并产生了高成本. 针对可疑的选择性方法在胃癌检测和资源分配方面更有效.
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: